International
Asia Pacific
Trinity has extensive experience supporting healthcare clients with a wide range of commercial business issues in the APAC region
Trinity supports global and local clients with commercialization strategies in the APAC region, in addition to supporting local clients with global expansion strategies
White Papers
Cracking the Code of the Access Landscape in China
As the market becomes increasingly crowded and budget constraints continue in China, downward pricing pressure to secure National Reimbursement Drug List (NRDL) inclusion remains the top challenge for multinational pharma companies in this market. However, the significant uptake post-NRDL inclusion and broad access offer substantial opportunities for innovative products with clinical differentiation. In this white […]
Read More
Blog
Japan’s Latest Drug Pricing Policy Updates: Key Changes and Expected Impact
A series of new drug pricing reforms came into effect in Japan in April 2022, to encourage innovation and ensure the transparency and predictability of drug pricing in the future. These include updates to the cost-accounting pricing methodology, an expansion of the scope of the Price Maintenance Premium (PMP)…
Read More
Webinars
Dragon’s Offer: Imparting Wisdom About Market Access Through the NRDL in China
What do pharmaceutical manufacturers need to know to successfully navigate the market access landscape in China through the latest NRDL update? The access landscape in China is rapidly evolving with important implications for novel medicines. The most recent update of China’s National Reimbursement Drug List (NRDL) in 2021 focused on…
Watch Now
If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.